Key result
Autism spectrum disorder in children is linked to ~29% higher fasting triglycerides and lower HDL-C.
Why the study?
Altered lipid profiles have been reported in autism spectrum disorder (ASD), but findings in pediatric populations are heterogeneous.
Case-Control (n=118)
No
Children under 10 years of age with autism spectrum disorder exhibit higher fasting triglycerides, lower HDL-C, and a higher triglyceride/HDL-C ratio compared to non-ASD peers undergoing similar elective preoperative evaluation.
Answers are grounded in this paper and cite their sources.
Higher triglycerides in ASD children should not yet alter lipid screening; hypothesis-generating and extends prior observational reports.
Background Altered lipid profiles have been reported in autism spectrum disorder (ASD), but pediatric findings are heterogeneous. We compared fasting lipid measures between children with ASD and non-ASD children sampled in a similar elective preoperative clinical context. Methods This single-center retrospective case-control study used electronic medical records from January 2018 to January 2025. The primary analysis included 71 children with ASD and 47 non-ASD children; all were younger than 10 years at blood sampling. In both groups, fasting lipid measurements were obtained as part of routine fasting preoperative testing requested by the surgical departments for elective non-metabolic surgical conditions such as inguinal hernia, hydrocele, or hemangioma; in the ASD group, sampling occurred after ASD diagnosis. Lipid testing was not prompted by suspected dyslipidemia or metabolic disease. Children with known hepatic, renal, endocrine, genetic, or metabolic disorders expected to affect lipid metabolism were excluded. Group differences were assessed before and after adjustment for age, sex, and BMI-for-age z score, with false-discovery-rate correction across five lipid measures. Results Children with ASD had higher triglycerides [0.75 (0.60–1.10) vs. 0.64 (0.51–0.82) mmol/L; 66.4 (53.1–97.4) vs. 56.7 (45.2–72.6) mg/dL], lower HDL-C (1.35 ± 0.29 vs. 1.52 ± 0.34 mmol/L; 52.2 ± 11.2 vs. 58.8 ± 13.1 mg/dL), and a higher derived triglyceride/HDL-C ratio [0.654 (0.428–0.853) vs. 0.413 (0.300–0.619)]. After adjustment, triglycerides were 29% higher (geometric mean ratio 1.29, 95% CI 1.10–1.52), HDL-C was 0.14 mmol/L (5.4 mg/dL) lower (adjusted mean difference − 0.14 mmol/L, 95% CI − 0.27 to − 0.02 mmol/L), and the triglyceride/HDL-C ratio was 43% higher (geometric mean ratio 1.43, 95% CI 1.16–1.76). LDL-C was higher in the primary analysis but was not robust in the expanded-comparison sensitivity analysis. At least one selected guideline lipid cut point (a threshold used to classify a lipid measurement) was met by 36.6% of children with ASD and 12.8% of the non-ASD surgical comparison group (absolute difference 23.9% points, 95% CI 7.8–37.3). Conclusions Children with ASD had higher fasting triglycerides, lower HDL-C, and consequently a higher triglyceride/HDL-C ratio than non-ASD children undergoing comparable elective preoperative assessment. These observational associations do not establish causality or imply an ASD-specific lipid disorder.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) conducted a case-control in Autism spectrum disorder (n=118). Autism spectrum disorder vs. Non-ASD children undergoing elective non-metabolic surgery was evaluated on Fasting lipid measures (triglycerides, HDL-C, triglyceride/HDL-C ratio, and meeting at least one selected guideline lipid cut point) (Geometric mean ratio 1.29 for triglycerides; MD -0.14 mmol/L for HDL-C; absolute difference 23.9% for guideline lipid cut point, 95% CI 1.10-1.52). Children with autism spectrum disorder had 29% higher fasting triglycerides and lower HDL-C than non-ASD surgical controls.
Synapse has enriched 10 related papers. Consider them for comparative context: